President Donald Trump’s proposed cut for the U.S. National Institutes of Health’s 2018 budget could stall advances in science for generations.

Scott Gottlieb is poised to become chief of the U.S. Food and Drug Administration, neuroscience research has blossomed over the past decade, and new grants support adults with autism.

The Chan Zuckerberg Initiative has pledged to provide financial support for bioRxiv, a website where researchers can share manuscripts before peer review.

Children with chronic conditions are especially vulnerable to health insurance changes, as they often rely on specialists and medications that may not be covered if they switch plans.

Eight pharmaceutical companies more than doubled their lobbying spending in the first three months of 2017.

Tens of thousands of people protested the U.S. administration’s anti-science policies on Saturday.

Facing acute risks to their businesses from Washington policymakers, health companies spent more than $2 million to buy access to the incoming Trump administration via candlelight dinners, black-tie balls and other inauguration events.

The March for Science is finally here, the scientific workforce is aging at an alarming rate, and a pint-size podcaster tackles serious science.

Critics say vulnerable patients are being manipulated and the goals promoted are skewed by the pharma benefactors who want faster government approval for new products.

Cell Press announces its new preprint server, Donald Trump has yet to name a science advisor, and new gene-editing tools are calling an old finding into question.